Latest News about NVCR
Recent news which mentions NVCR
   Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2022
   
  
  
  February 08, 2022
  From Benzinga
 
   3 Amazing Stocks That Are 60% Off Their Highs
   
  
  
  February 04, 2022
  From Motley Fool
 
   3 Growth Stocks to Buy That Have Crashed More Than 60%
   
  
  
  February 04, 2022
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
   
  
  
  February 02, 2022
  From Benzinga
 
   3 Healthcare Stocks That Are Too Cheap to Ignore
   
  
  
  January 30, 2022
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
   
  
  
  January 20, 2022
  From Benzinga
 From Benzinga
 
   3 Top Healthcare Stocks to Buy for January
   
  
  
  January 08, 2022
  From Motley Fool
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  January 06, 2022
  From Benzinga
 
   7 Pharmaceutical Stocks That Could Make You Rich
   
  
  
  January 06, 2022
  From InvestorPlace
 
   Stocks That Hit 52-Week Lows On Wednesday
   
  
  
  January 05, 2022
  From Benzinga
 
   Stocks Hitting New 52-Week Lows Today
   
  
  
  January 03, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
   
  
  
  January 03, 2022
  From Benzinga
 
   3 Biotech Stocks That Are Too Cheap to Ignore
   
  
  
  December 19, 2021
  From Motley Fool
 
   Is It Time to Buy the 3 Worst-Performing Growth Stocks of 2021?
   
  
  
  December 03, 2021
  From Motley Fool
 
   These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs
   
  
  
  November 29, 2021
  From MarketWatch
 
   Novocure Posts Data For Tumor Treating Fields In Brain Tumor Trial
   
  November 15, 2021
  Tickers 
   NVCR
  
  
  From Benzinga
 
   3 Healthcare Stocks That Could Be Turkeys in November
   
  
  
  October 29, 2021
  From Motley Fool
 From Benzinga
 
   Earnings Scheduled For October 28, 2021
   
  
  
  October 28, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
   
  
  
  October 24, 2021
  From Benzinga
 
   3 Stocks to Consider if the October Stock Market Sell-Off Worsens
   
  
  
  October 17, 2021
  From Motley Fool
 
   This Unstoppable Cancer-Treatment Company's Stock Is on Sale Now
   
  October 14, 2021
  Tickers 
   NVCR
  
  
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


